What’s Driving Pfizer’s Pursuit of AstraZeneca?

April 28 (Bloomberg) -- Bloomberg’s Drew Armstrong examines what Pfizer stands to gain from its $98.7 billion pursuit of AstraZeneca on Bloomberg Television’s “Market Makers.”

Most Recent Videos

U.S. Economy Not Showing a Lot of Momentum: Piegza
37:29 - Jan. 30 -- Sterne Agee's Lindsey Piegza and Bloomberg Intelligence's Carl Riccadonna discuss the slowdown in U.S. growth with Bloomberg's Alix Steel and Lisa Abramowicz on "Street Smart."
  • Oil Rebounds on Speculation Low Prices Will Slow Output
  • Tiger Woods to `Keep Fighting' After Career-Worst Round
  • Deutsche Bank's London Office Under Supervisory Watch